| pubmed-article:2964839 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2964839 | lifeskim:mentions | umls-concept:C0019080 | lld:lifeskim |
| pubmed-article:2964839 | lifeskim:mentions | umls-concept:C0023903 | lld:lifeskim |
| pubmed-article:2964839 | lifeskim:mentions | umls-concept:C0013931 | lld:lifeskim |
| pubmed-article:2964839 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:2964839 | lifeskim:mentions | umls-concept:C0116757 | lld:lifeskim |
| pubmed-article:2964839 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2964839 | pubmed:dateCreated | 1988-5-2 | lld:pubmed |
| pubmed-article:2964839 | pubmed:abstractText | Two patients with abdominal hemorrhage from a hepatic tumor underwent transcatheter embolization using Ethibloc. The hemorrhage ceased rapidly in both patients. No complications related to the embolization procedure were observed. One patient is doing well after 4 years. The second patient died of extensive metastatic disease eleven weeks after embolization. Control angiography after 14 months and 2 weeks, respectively, demonstrated persistent occlusion of the embolized hepatic arteries. Ethibloc offers the advantage of permanent vascular occlusion and appears to be a safe and effective embolization material for partial occlusion of the hepatic arteries. | lld:pubmed |
| pubmed-article:2964839 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2964839 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2964839 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2964839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2964839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2964839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2964839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2964839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2964839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2964839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2964839 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2964839 | pubmed:issn | 0284-1851 | lld:pubmed |
| pubmed-article:2964839 | pubmed:author | pubmed-author:HoevelsJJ | lld:pubmed |
| pubmed-article:2964839 | pubmed:author | pubmed-author:JaschkeWW | lld:pubmed |
| pubmed-article:2964839 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2964839 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:2964839 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2964839 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2964839 | pubmed:pagination | 15-9 | lld:pubmed |
| pubmed-article:2964839 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:2964839 | pubmed:meshHeading | pubmed-meshheading:2964839-... | lld:pubmed |
| pubmed-article:2964839 | pubmed:meshHeading | pubmed-meshheading:2964839-... | lld:pubmed |
| pubmed-article:2964839 | pubmed:meshHeading | pubmed-meshheading:2964839-... | lld:pubmed |
| pubmed-article:2964839 | pubmed:meshHeading | pubmed-meshheading:2964839-... | lld:pubmed |
| pubmed-article:2964839 | pubmed:meshHeading | pubmed-meshheading:2964839-... | lld:pubmed |
| pubmed-article:2964839 | pubmed:meshHeading | pubmed-meshheading:2964839-... | lld:pubmed |
| pubmed-article:2964839 | pubmed:meshHeading | pubmed-meshheading:2964839-... | lld:pubmed |
| pubmed-article:2964839 | pubmed:meshHeading | pubmed-meshheading:2964839-... | lld:pubmed |
| pubmed-article:2964839 | pubmed:meshHeading | pubmed-meshheading:2964839-... | lld:pubmed |
| pubmed-article:2964839 | pubmed:meshHeading | pubmed-meshheading:2964839-... | lld:pubmed |
| pubmed-article:2964839 | pubmed:meshHeading | pubmed-meshheading:2964839-... | lld:pubmed |
| pubmed-article:2964839 | pubmed:meshHeading | pubmed-meshheading:2964839-... | lld:pubmed |
| pubmed-article:2964839 | pubmed:meshHeading | pubmed-meshheading:2964839-... | lld:pubmed |
| pubmed-article:2964839 | pubmed:meshHeading | pubmed-meshheading:2964839-... | lld:pubmed |
| pubmed-article:2964839 | pubmed:articleTitle | Control of hepatic tumor hemorrhage by transcatheter embolization with Ethibloc. | lld:pubmed |
| pubmed-article:2964839 | pubmed:affiliation | Institut für Klinische Radiologie, Fakultät für Klinische Medizin, Universität Heidelberg, Mannheim, West Germany. | lld:pubmed |
| pubmed-article:2964839 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2964839 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2964839 | lld:pubmed |
